Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California


Recent News and Articles on the Keywords: fentanyl + pain + breakthrough  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 10 of about 27 for fentanyl pain breakthrough. (1.43 seconds) 
 Sorted by relevance   Sort by date   Sort by date with duplicates included 
Akela Pharma reports results for the third quarter of fiscal 2008
FOXBusiness - Nov 14, 2008
Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder ...TSE:AKL
Cephalon and ImmuPharma Sign a $15 million Option Agreement for ...
MarketWatch - Nov 25, 2008
ImmuPharma is a currently developing drug candidates for five different medical conditions, each of which would represent a significant breakthrough in its ...CEPH - LON:IMM

Business Wire (press release)
BioDelivery Sciences to Meet with FDA to Finalize Proposed REMS ...
Business Wire (press release), CA - Nov 7, 2008
ONSOLIS (formerly known as BEMA ? Fentanyl), the company?s lead product in development, is a potential treatment for ?breakthrough? pain in opioid tolerant ...BDSI
Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha, NY - Nov 18, 2008
... also we call as Staccato fentanyl, and we are developing this product in conjunction with Endo Pharmaceuticals for the treatment of breakthrough pain in ...ALXA
BioDelivery Sciences Remains on Schedule for December ONSOLIS ...
MarketWatch - Nov 19, 2008
ONSOLIS (formerly known as BEMA(TM) Fentanyl), the company's lead product in development, is a potential treatment for "breakthrough" pain in opioid ...
BioDelivery Sciences to Meet with FDA to Finalize Proposed REMS ...
PR-Inside.com (Pressemitteilung), Austria - Nov 9, 2008
ONSOLIS (formerly known as BEMA(TM) Fentanyl), the company's lead product in development, is a potential treatment for "breakthrough" pain in opioid ...
BioDelivery Sciences to Present at the Rodman & Renshaw and Lazard ... PR-Inside.com (Pressemitteilung)
all 3 news articles »  BDSI - RODM
BioDelivery Sciences to Present at the Rodman & Renshaw and Lazard ...
Trading Markets (press release), CA - Nov 6, 2008
During both conferences, Dr. Sirgo will be presenting an update on the status of BDSI's lead product, ONSOLIS(TM), formerly known as BEMA(TM) Fentanyl. ...BDSI - RODM
Alexza Pharmaceuticals Announces Upcoming Conference Participation ...
MarketWatch - Nov 11, 2008
Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo ...ALXA
Alexza Reports 2008 Third Quarter Financial Results and Updates ...
Earthtimes (press release), UK - Nov 6, 2008
Alexza is jointly developing Staccato fentanyl with Endo Pharmaceuticals, Inc., or Endo, for the treatment of breakthrough pain. ...ALXA
The opioid market is currently valued at $7.7 billion and is set ...
Live-PR.com (Pressemitteilung), Austria - Nov 9, 2008
... value over the next 10 years, driven by Cephalon's Fentora for use in breakthrough pain, and supported by other new short-acting fentanyl formulations. ...
Source: Google News


 

Recent News and Articles on the Keywords: fentanyl + lozenge + 69,200  Related to the article below (Last Update: 8/7/2008)


eFluxMedia
CDC Reports More Than 1000 Deaths From Illegal Fentanyl Overdoses
eFluxMedia - Jul 25, 2008
When prescribed by a physician, fentanyl is often administered via injection, transdermal patch, or in lozenge form. According to the report, the fentanyl ...

HealthNews
Overdoses From Illegal Fentanyl on the Rise in the US
HealthNews, CA - Jul 27, 2008
... injection, or in the form of a lozenge. Drug dealers on the streets of America are selling the drug illegally in powder form. The fentanyl was also ...
Face of war: Soldier rebuilding his life and body
MiamiHerald.com, FL - Jul 13, 2008
When his dressings were changed, or dead skin was scrubbed off and the pain became unbearable, he sucked on a fentanyl lollipop, a sweetened lozenge on a ...
Source: Google News

Fentanyl Metabolism by Human Hepatic and Intestinal Cytochrome P450 3A4: Implications for … -
RB Labroo, MF Paine, KE Thummel, ED Kharasch - Drug Metabolism and Disposition, 1997 - ASPET
... The fraction of fentanyl lozenge that is swallowed likely undergoes significant
intestinal, as well as hepatic, first-pass metabolism. ...

Comparison of Oral Transmucosal Fentanyl Citrate and Intramuscular Meperidine, Promethazine, and … -
SA Schutzman, E Liebelt, M Wisk, J Burg - Annals of Emergency Medicine, 1996 - Elsevier
... Then, at time zero, a nurse either administered a fentanyl lozenge and placed a
bandage on the child's leg or administered IM MPC and a placebo lozenge. ...

The Use of Spinal Cord Stimulation in Refractory Abdominal Visceral Pain: Case Reports and … -
JM Tiede, SM Ghazi, TJ Lamer, JB Obray - Pain Practice, 2006 - pt.wkhealth.com
... duration. Her medical regimen consisted of gabapentin, fentanyl lozenge, diazepam,
promethazine, and tegaserod maleate. Radiofrequency ...

The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young … -
RH Epstein - Anesthesia & Analgesia, 1996 - IARS
... receive OTFC/intravenous (IV) saline or placebo lozenge/IV fentanyl. ... Pa- tients
who had been given the placebo lozenge re- ceived fentanyl 1.2 ? ...

Fentanyl: A Review for Clinical and Analytical Toxicologists -
A Poklis - Clinical Toxicology, 1995 - informaworld.com
... Presently, a fentanyl lozenge with a handle (lollipop) is being investigated as
premedication for surgical procedures for pediatric and cancer patients (19). ...

Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients … -
RH Friesen, CH Lockhart - Anesthesiology, 1992 - ncbi.nlm.nih.gov
... he safety and efficacy of oral transmucosal fentanyl citrate (OTFC) as a preanesthetic ...
groups and managed in a double-blinded manner: 1) placebo lozenge 45 min ...

… Midazolam Plus Placebo Versus Oral Midazolam Plus Oral Transmucosal Fentanyl for Sedation During … -
EJ Klein, DS Diekema, CA Paris, L Quan, M Cohen, … - Pediatrics, 2002 - Am Acad Pediatrics
... The patient was then given the fentanyl or placebo lozenge, and ED nursing staff
applied lidocaine, epinephrine, and tetracaine to the wound (if appropriate). ...

Oral transmucosal fentanyl citrate for preanaesthetic medication of paediatric cardiac surgery … -
RH FRIESEN, E CARPENTER, CK MADIGAN, CH LOCKHART - Pediatric Anesthesia, 1995 - Blackwell Synergy
... anaesthesia. oral transmucosal fentanyl citrate (OTFC), admin- istered
in the form of a lozenge on a handle, has Correspondence ...

A Comparison of Oral Transmucosal Fentanyl Citrate and Oral Oxycodone for Pediatric Outpatient Wound … -
SR Sharar, GJ Carrougher, K Selzer, FO'Donnell, MS … - Journal of Burn Care & Research, 2002 - burncarerehab.com
... OTFC is a raspberry-flavored, fentanyl-impregnated lozenge that is applied directly
to the buccal mucosa, resulting in rapid fentanyl uptake directly into the ...

Current pharmacotherapy for the treatment of severe burns -
KD Murphy, JO Lee, DN Herndon - eop, 2003 - Expert Opinion
... Oral transmucosal fentanyl lozenge (Oralet?, Anesta) is frequently used
for out-patient hydrotherapy. Sharar et al. showed that ...

Source: Google Scholar
 
 

Effectiveness of Fentanyl lozenges for breakthrough cancer pain

Fentanyl relieves breakthrough pain quickly and more effectively than other narcotics and traditional drug therapy in patients with cancer.

Breakthrough pain is moderate to severe sudden pain that interrupts otherwise controlled, persistent pain in people already taking pain medicine. The Fentanyl lozenge, known as oral transmucosal Fentanyl citrate, or OTFC, is also known by the brand name Actiq.

The review, led by Giovambattista Zeppetella, of the St. Clare Hospice in England, comprised four randomized controlled trials of a total 393 patients with cancer.
Patients received OTFC for breakthrough pain and relief was compared with Morphine or other opioid rescue medication, or placebo.

The review is published in The Cochrane Library.

OTFC was specifically developed for breakthrough pain and approved by the FDA in 1998, and is used only by patients who are already taking other narcotic pain medications.
It is exponentially more potent than Morphine.

Current treatment for breakthrough pain typically involves so-called "rescue medication", a supplemental dose of a patient's current pain medication.
The review findings showed that Fentanyl is more effective.

Forty-eight study patients who previously used narcotics other than Morphine were able to find a safe and effective dose of Fentanyl and rated it as better for breakthrough than their usual rescue pain medication; 93 patients who traditionally used Morphine reported a 33 percent higher change in pain intensity and pain relief at 15 minutes with Fentanyl; and 93 of 130 patients who received Fentanyl found a safe and effective dose and rated the drug higher than placebo for relief.

" OTFC was reported to produce a greater analgesic effect, better global satisfaction and a more rapid onset of action than the usual rescue medication or placebo," the authors conclude.

According to Zeppetella, the superior results may be due to a number of factors. " The faster onset and shorter duration of action of OTFC more closely match the characteristics of most breakthrough pain," Zeppetella said. The lozenge is placed within the cheek and gum, a site that " has a wide surface, is well-vascularized and facilitates absorption." The lozenge dissolves within 10 minutes, with only about 5 percent remaining. The medicine is then quickly absorbed and moved into the central nervous system to quell pain, Zeppetella said.

Despite the positive outcomes, treating breakthrough pain is ultimately a matter of customizing treatment for each patient, depending on the specific cause and site of the breakthrough pain, Zeppetella said. " The ideal treatment for breakthrough pain is an analgesic with good efficacy, a rapid onset of action, a short duration of action and minimal adverse effects. Irrespective of the drug, the pharmacokinetic profile will need to match the characteristics of breakthrough pain."

Another expert agrees that OTFC is not the only or definitive treatment for cancer pain. " This review mostly points out the paucity of appropriate studies of breakthrough pain," said Charles F. von Gunten, editor in chief of the Journal of Palliative Medicine. He noted that the review is not a comprehensive study of all opioids; rather, " it is only four studies of OTFC." He said, " The principal barrier to adequately treating breakthrough pain is accurate diagnosis and the utilization of existing medications in appropriately aggressive ways."

Side effects of Fentanyl include dizziness, feeling faint, lightheadedness, unusual tiredness or weakness, shortness of breath, anxiety, confusion or hallucinations. Less serious side effects include constipation, dry mouth and nausea or vomiting.

Source: Center for the Advancement of Health, 2006

 
 
 
Google
Web www.iconocast.com
 
 

 

Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; Nedws9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page